TTRX · Turn Therapeutics Inc.
$9.84
-0.27 (-2.67%)
At close · Aug 28
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that these condensed consolidated financial statements as of June 30, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Market Cap
$293.11M
Shares
29.79M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-07 | GX-03 Phase 2 Update: A Detailed Review of Key Stage 1 Findings and the Data-Driven Stage 2 Design | Webcast |
| 2026-06-04 | Jefferies Global Healthcare Conference 2026 | Conference |
| 2026-03-02 | 46th Annual TD Cowen Healthcare Conference in Boston, MA | Conference |
| 2026-02-25 | 36th Annual Oppenheimer Healthcare Life Sciences Conference (Virtual) | Conference |
Source: https://ir.turntherapeutics.com/
Key facts
CIK
2023016
CUSIP
90021W105
13F (30d)
22 filings
22 filers
Visit website
Investor relations